Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 956 results found. Search for [ Indian pharma companies in US ]

Results 1 to 21 of 956
Rupa Burman Roy
June 5, 2020
Barring FMCG that fell marginally and IT sector that closed flat, all other indices ended on a bullish note, with PSU Bank rising 6.8%, followed by 5.2% rise in media stocks and 3.8% gain in metal scrips


BusinessToday.In
New Delhi, June 5, 2020
COVID-19 drug: The clinical trial will be conducted across 12 centres in India in 210 patients for 10 days and the results of the clinical trial are expected by October


BusinessToday.In
June 5, 2020
Stock Market LIVE Updates: Companies set to announce their earnings are State Bank of India, L&T, Jyothi Labs, Exide Industries, Saregama, Alkem Laboratories, Greaves Cotton, Gujarat Gas among others.


BusinessToday.In
New Delhi, June 4, 2020
Coronavirus update: ICMR said ELISA tests are to be used for only two purposes - sero-surveys and survey among vulnerable or high-risk populations, including healthcare workers, frontline workers, or those in containment zones


BusinessToday.In
New Delhi, June 4, 2020
COVID 19 Vaccine News India: The government has now permitted a few relaxations to the Drugs and Cosmetics Act, 1940


Rajeev Dubey
New Delhi, June 4, 2020
The reason India finds itself in the comity of nations that can't afford a big stimulus to stoke economic growth is the 8 quarters of wait-and-watch game played until coronavirus hit us


BusinessToday.In
June 4, 2020
Stock Market LIVE Updates: Indian Oil, ONGC, Titan, M&M, ONGC and HDFC were among the top laggards today, while Sun Pharma, TCS, PowerGrid, HDFC Bank, HCL Tech and ICICI Bank were the top performers today.


BusinessToday.In
New Delhi, June 3, 2020
WHO chief Tedros Adhanom Ghebreyesus  said that clinical trials of anti-malaria drug hydroxychloroquine will resume as a potential treatment for coronavirus


BusinessToday.In
June 2, 2020
Stock Market LIVE Updates: Kotak Bank, M&M, Tata Motors, Hindalco, Bajaj Finance were among the top gainers on Nifty. On the contrary, Coal India, L&T, ITC, ICICI Bank and BPCL were among the major losers


PTI
June 2, 2020
The drug has been allowed for restricted emergency use for treatment of suspected or laboratory-confirmed cases of COVID-19 in adults and children hospitalised with severe symptoms, subject to several safeguards, the source said


Rupa Burman Roy
June 1, 2020
Reduced US-China geopolitical tensions after US President Donald Trump stopped short of threatening tariffs on China and private survey data showing that China's manufacturing sector moved into expansion territory in May also boosted market sentiments


BusinessToday.In
June 1, 2020
Stock Market LIVE Updates: Axis Bank, Tata Steel, Bajaj Finance, IndusInd Bank, SBI, ICICI Bank and HDFC twins were among the top gainers on Sensex pack. On the other hand, Sun Pharma was the sole laggard


PTI
May 30, 2020
Gilead Sciences Inc have entered into non-exclusive licensing agreements with pharma firms including three domestic majors Cipla, Jubilant Life Sciences and Hetero for manufacture and distribution of remdesivir


PTI
May 29, 2020
Ahead of US President Donald Trump's maiden visit to India in February, there were reports that the two sides would sign the first phase of a mega trade deal


BusinessToday.In
May 29, 2020
Stock Market LIVE Updates: Axis Bank, followed by IndusInd Bank, Bajaj Finance, Tata Steel, Infosys, HDFC twins and ICICI Bank were among the top losers. On the contrary, Bajaj Auto, ITC, Sun Pharma, Asian Paints and L&T were among the top gainers on Sensex pack.


Aseem Thapliyal
May 29, 2020
It seems investors are sitting on boundaries in a wait-and-watch mode and traders are reaping gains from the volatility cycle in which the benchmark indices are stuck.


BusinessToday.In
New Delhi, May 28, 2020
Coronavirus vaccine update: Even though these candidate vaccines have produced encouraging results in early stages, a clearer picture can only emerge when a diverse population gets tested


PB Jayakumar
May 27, 2020
Approval to explore new COVID-19 therapies, licensing and supply deals to manufacture drugs to treat the virus and fast approvals for plants under regulatory scanner have turned the fortunes of most of these companies


BusinessToday.In
May 27, 2020
COVID-19 vaccine latest status: Researchers across the world are of the opinion that it will take another 14-18 months to get access to a potent coronavirus drug


E Kumar Sharma
New Delhi, May 27, 2020
Coronavirus crisis: WHO is currently assessing the use of hydroxychloroquine on COVID-19 patients within the Solidarity Trial. The hydroxychloroquine arm of the trial has been paused as a precaution while the safety data is being reviewed.


PAGES 1 OF 48  12345